- Home
- CRDF vs HOND Comparison
CRDF vs HOND Comparison
Compare CRDF & HOND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- HOND
- Stock Information
- Founded
- CRDF 1999
- HOND 2024
- Country
- CRDF United States
- HOND United States
- Employees
- CRDF N/A
- HOND N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- HOND
- Sector
- CRDF Health Care
- HOND
- Exchange
- CRDF Nasdaq
- HOND NYSE
- Market Cap
- CRDF 233.5M
- HOND 334.9M
- IPO Year
- CRDF N/A
- HOND 2024
- Fundamental
- Price
- CRDF $4.04
- HOND $10.89
- Analyst Decision
- CRDF Strong Buy
- HOND
- Analyst Count
- CRDF 6
- HOND 0
- Target Price
- CRDF $11.92
- HOND N/A
- AVG Volume (30 Days)
- CRDF 1.5M
- HOND 361.1K
- Earning Date
- CRDF 08-07-2025
- HOND 01-01-0001
- Dividend Yield
- CRDF N/A
- HOND N/A
- EPS Growth
- CRDF N/A
- HOND N/A
- EPS
- CRDF N/A
- HOND 0.20
- Revenue
- CRDF $587,000.00
- HOND N/A
- Revenue This Year
- CRDF N/A
- HOND N/A
- Revenue Next Year
- CRDF N/A
- HOND N/A
- P/E Ratio
- CRDF N/A
- HOND $53.55
- Revenue Growth
- CRDF N/A
- HOND N/A
- 52 Week Low
- CRDF $2.01
- HOND $9.90
- 52 Week High
- CRDF $5.64
- HOND $12.24
- Technical
- Relative Strength Index (RSI)
- CRDF 65.93
- HOND N/A
- Support Level
- CRDF $3.07
- HOND N/A
- Resistance Level
- CRDF $4.22
- HOND N/A
- Average True Range (ATR)
- CRDF 0.22
- HOND 0.00
- MACD
- CRDF 0.08
- HOND 0.00
- Stochastic Oscillator
- CRDF 87.35
- HOND 0.00
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About HOND HCM II ACQUISITION CORP
HCM II Acquisition Corp is a blank check company.